
ecosera brings together sponsors, CROs, research sites, vendors, and patients on a single governed platform — from funding and protocol design to trial execution, regulatory compliance, and compassionate use.
Powered by AxellaCoin (AXC), ecosera links how a trial is financed to how it is run: capital is raised for one trial, released only as each milestone is verified on the platform, and reported back from live trial data, all aligned around one shared goal — getting better science to patients faster.
This isn't software for clinical research. It's the infrastructure clinical research has always needed.
Whether you fund research, run trials, or participate in them — ecosera connects the entire drug development lifecycle.
Upload protocols, generate budgets with AI, distribute RFPs to qualified CROs, and finance individual trials with milestone-gated capital.
Finance one trial at a time. Capital is held in escrow and released only when an independently verified milestone is met. Accredited investors hold economic rights in the trial they fund; AXC holders take part in platform governance.
Receive targeted RFPs matching your capabilities, build bids with FMV benchmarking, manage site networks, and get paid in AXUSD.
Manage patient enrollment, regulatory documents, visit schedules, and receive per-patient payments directly through the platform.
Find clinical trials matching your condition, track visit schedules, receive stipend payments, and manage your health data privately.
Apply for trial-level funding. AI turns your research into an investor-ready pitch, an expert scientific and investment committee reviews it, and capital is released in tranches as milestones are verified.
The full drug development lifecycle in one integrated platform.

Purpose-built on Cardano. Governance, operations, and trial economics — each with a distinct token role.
Platform governance: holders vote on material changes and elect an investor representative. Funding decisions sit with an expert committee, and releases follow verified milestones, not votes. AXC carries no equity, ownership or profit rights.
Stablecoin for all platform payments — CRO bids, site payments, vendor invoices, patient stipends. Every payment reconciles to a milestone.
Economic rights in one funded trial through a trial-specific SPV: a tiered royalty on the molecule (full rate in the funded indication, reduced in follow-on indications) and a share of licensing or exit proceeds, capped at a multiple. Unreleased tranches return to investors if a trial stops. Accredited investors only (Reg D 506(c) / Reg S).
The AxellaCoin trial-financing model described here is in development and not yet available. Royalty and return terms are set per trial in its offering documents. Nothing on this site is an offer to sell, or a solicitation of an offer to buy, any security or token.
Browse funded studies and upcoming investment opportunities. No login required.

Finance clinical research one trial at a time. An expert committee selects programs, capital is released only as Ecosera verifies each milestone, and accredited investors hold economic rights in the trial they fund. Submit your pitch deck and our AI extracts deal data instantly.

Join the first decentralized platform connecting sponsors, CROs, sites, and patients in a single operating system for drug development.
A narrated tour for sponsors — drug program and FDA submission tracking, AI protocol review, RFPs to CROs, site readiness, source-to-CRF with remote SDV, and SAE reporting. Want the full guided walkthrough? Request access and we'll send you a passcode.